Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months - Williet, N; Boschetti, G; Fovet, M (Clin Gastroenterol Hepatol, 2017)
et al.